Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Non GLP study. The study was conducted according to a method equivalent to the OECD 408 guideline without major deviations. However, no data on test conditions, preparation of animals are reported. Follow-up of body weight was done weekly, however no individual animal data were reported. No histopathology observations were done. No individual reporting was done.
Reason / purpose for cross-reference:
reference to same study

Data source

Reference Type:
The acute, chronic and topical toxicity of zirconium carbonate.
Harrison J.W.E., Trabin B, Martin E.W
Bibliographic source:
J Pharmacol Exp Ther; 102(3): 179-84

Materials and methods

Test guideline
equivalent or similar to guideline
OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
no histopathology was done, detailed data on study set-up and results are lacking
GLP compliance:
Limit test:

Test material

Constituent 1
Reference substance name:
Cas Number:
Molecular formula:
Constituent 2
Reference substance name:
Constituent 3
Reference substance name:
Zirconium basic carbonate
Zirconium basic carbonate
Details on test material:
- Name of test material (as cited in study report): hydrated zirconium carbonate
- Composition of test material, percentage of components: containing 20.9 % ZrO2
- Molecular formula (if other than submission substance): 3ZrO2.CO2.H2O
- Physical state: water insoluble moist paste
- Analytical purity: no data
- Impurities (identity and concentrations): no data

Test animals

other: Albino
Details on test animals or test system and environmental conditions:
- Source: no data
- Age at study initiation: recently weaned
- Weight at study initiation: 50 g
- Fasting period before study: no data
- Housing: no data
- Diet (e.g. ad libitum): normal diet
- Water (e.g. ad libitum): normal diet
- Acclimation period: no data

Administration / exposure

Route of administration:
oral: feed
unchanged (no vehicle)
Details on oral exposure:
Three groups of 20 rats each were distributed as litter mates and fed during 17 weeks with a mixture of standard rat diet and hydrated zirconium carbonate (HZC) at 0.2%, 2.0% and 20% (w/w).
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
17 weeks
Frequency of treatment:
continuously in the diet
Doses / concentrationsopen allclose all
Doses / Concentrations:
0.2% (w/w) equivalent of 300 to 130 mg/kg bw/day calculated in week 1 and week 15 respectively
nominal in diet
Doses / Concentrations:
2.0% (w/w) equivalent of 3300 to 1300 mg/ kg bw/day calculated week 1 and week 15 respectively
nominal in diet
Doses / Concentrations:
20% (w/w) equivalent of 33900 to 15100 mg/kg bw/day calculated week 1 and week 15 respectively
nominal in diet
No. of animals per sex per dose:
10 males and 10 females
Control animals:
yes, plain diet
Details on study design:
Three groups of 20 rats each were distributed as litter mates.
Positive control:
No positive control


Observations and examinations performed and frequency:
Animals observed daily and weighed weekly. Records were kept of the quantities of food and water consumed.
Sacrifice and pathology:
Gross pathology of the organs.
Other examinations:
- Sample of blood were obtained from 8 animals in each group ( 4 males/4 females) at the weeks 8 & 16 of the test
- Hemoglobin was determined, erythrocytes and leucocytes were counted, and differential counts were made
- Urine was also examined
No data

Results and discussion

Results of examinations

Clinical signs:
no effects observed
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
no effects observed
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
not examined
Urinalysis findings:
no effects observed
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
not examined
Histopathological findings: neoplastic:
not examined
Details on results:
- No mortality during the test
- Growth curves were normal and identical to control rats
- No significant differences in the hematologic findings were noted among the various groups examined
- The urine did not differ significantly among the groups in color, reaction, odor, albumin content or microscopic appearance
- for all animals, their fur was smooth, their eyes and noses were clear and their mucous membranes were healthy in appearance
- The heart, lungs, thyroid, thymus, liver, spleen, kidneys, adrenals, stomach, intestines, bladder and genital organs were grossly normal in all animals

Effect levels

Dose descriptor:
Effect level:
3 150 - 7 080 mg/kg bw/day (actual dose received)
Based on:
other: 20.9% ZrO2 in the test material (HZC)
Basis for effect level:
other: The NOAEL is based on the daily consumption calculated from equivalent intake levels of ZrO2 and body weights of rats.

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

Level of HZC in diet: 0%, 0.2%, 2.0% and 20%

Total intake food: 2182 g, 2176 g, 2149 g and 2475 g

Total intake ZrO2: 0 g, 0.9 g, 9.0 g and 103.5 g

Total intake water: 4193 g, 4774 g, 4097 g and 4021 g

Initial weight males: 52 -54 g; females: 50 -51 g

Weight after 17 weeks males: 340 -349 g; females 210 -230 g

Weight gain (average) males: 285 -295 g; females 160 -179 g

Daily consumption of HZC: 0, 0.13 -0.30 g/kg, 1.3 -3.3 g/kg and 15.1 - 33.9 g/kg

Applicant's summary and conclusion

Ingestion of equivalent cumulative doses of 0.9 g, 9 g and 103.5 g of ZrO2 in the form of hydrated zirconium carbonate for a period of 17 weeks does not cause any death on the 60 rats submitted to the test. This indicate the absence of cumulative toxic effects. After autopsy, no abnormality was observed on heart, lungs, thyroids, thymus, liver, spleen, kidneys, adrenals, stomach, intestines, bladder and genitals organs, so it can be concluded that ingestion of HZC (containing 20.9% ZrO2) does not induce harmful effects.